The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Cellular Classification of Adult Hodgkin Lymphoma

Added Nogová et al. as reference 6.

Stage Information for Adult Hodgkin Lymphoma

Added Terasawa et al. as reference 10.

Advanced Unfavorable Hodgkin Lymphoma

Added text to include CEC on the list of drug combinations.

Added text to update the statistics for 10-year survival rates from treatment and 10-year actuarial rates after diagnosis (cited Engert et al. as reference 5).

Added text to include a prospective randomized trial of patients with advanced-stage disease that compared ABVD, BEACOPP, and CEC; the results showed no significant difference in overall survival (cited Federico et al. as reference 6 and level of evidence 1iiDiii).

Recurrent Adult Hodgkin Lymphoma

Added Thompson et al. as reference 22.

Back to Top

< Previous Section  |  Next Section >